These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15231240)

  • 1. Does cellular iron dysregulation play a causative role in Parkinson's disease?
    Kaur D; Andersen J
    Ageing Res Rev; 2004 Jul; 3(3):327-43. PubMed ID: 15231240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
    Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease.
    Song N; Wang J; Jiang H; Xie J
    Free Radic Biol Med; 2010 Jan; 48(2):332-41. PubMed ID: 19913091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
    Maguire-Zeiss KA; Short DW; Federoff HJ
    Brain Res Mol Brain Res; 2005 Mar; 134(1):18-23. PubMed ID: 15790526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron transport in Parkinson's disease.
    Hirsch EC
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synucleins and their relationship to Parkinson's disease.
    von Bohlen Und Halbach O
    Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic effects of alpha-synuclein aggregation.
    Lundvig D; Lindersson E; Jensen PH
    Brain Res Mol Brain Res; 2005 Mar; 134(1):3-17. PubMed ID: 15790525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease.
    Zhou Y; Shie FS; Piccardo P; Montine TJ; Zhang J
    Neuroscience; 2004; 128(2):281-91. PubMed ID: 15350641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein: normal function and role in neurodegenerative diseases.
    Norris EH; Giasson BI; Lee VM
    Curr Top Dev Biol; 2004; 60():17-54. PubMed ID: 15094295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum.
    Galy B; Ferring-Appel D; Kaden S; Gröne HJ; Hentze MW
    Cell Metab; 2008 Jan; 7(1):79-85. PubMed ID: 18177727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
    Sidhu A; Wersinger C; Vernier P
    FEBS Lett; 2004 May; 565(1-3):1-5. PubMed ID: 15135042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease.
    Ahlskog JE
    Mov Disord; 2005 Mar; 20(3):271-82. PubMed ID: 15580550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divalent metal transporter, iron, and Parkinson's disease: a pathological relationship.
    Lee HP; Zhu X; Liu G; Chen SG; Perry G; Smith MA; Lee HG
    Cell Res; 2010 Apr; 20(4):397-9. PubMed ID: 20357807
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenesis of Parkinson's disease.
    Sherer TB; Betarbet R; Greenamyre JT
    Curr Opin Investig Drugs; 2001 May; 2(5):657-62. PubMed ID: 11569943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene dosage and pathogenesis of Parkinson's disease.
    Eriksen JL; Przedborski S; Petrucelli L
    Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?
    Andersen JK
    Novartis Found Symp; 2001; 235():11-20; discussion 20-5. PubMed ID: 11280021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.